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Abstract: We report the use of optical coherence tomography (OCT) to 
determine spatially localized optical attenuation coefficients of human 
axillary lymph nodes and their use to generate parametric images of 
lymphoid tissue. 3D-OCT images were obtained from excised lymph nodes 
and optical attenuation coefficients were extracted assuming a single 
scattering model of OCT. We present the measured attenuation coefficients 
for several tissue regions in benign and reactive lymph nodes, as identified 
by histopathology. We show parametric images of the measured attenuation 
coefficients as well as segmented images of tissue type based on 
thresholding of the attenuation coefficient values. Comparison to histology 
demonstrates the enhancement of contrast in parametric images relative to 
OCT images. This enhancement is a step towards the use of OCT for in situ 
assessment of lymph nodes. 
© 2012 Optical Society of America 
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1. Introduction 
The lymphatic system, which comprises the network of nodes and vessels through which 
lymph circulates throughout the body, is a common pathway for the metastatic spread of 
cancer. For patients with early stage breast cancer, the presence or absence of malignant 
deposits in axillary lymph nodes is the single most important prognostic indicator [1]. 
Histological assessment of excised lymph nodes is the current gold standard for 
determining lymph node status (i.e. the presence or absence of metastatic deposits) in patients 
with malignancy. Dissection of most or all of the axillary lymph nodes (axillary clearance) is 
a standard surgical treatment for breast cancer patients with metastatic involvement of lymph 
nodes, having both a therapeutic and diagnostic function [2]. However, the procedure may be 
complicated by lymphedema, the chronic swelling and immovability of the arm caused by 
fluid retention from disruption of lymphatic pathways [3]. 
Sentinel lymph node biopsy is a common procedure to assess axillary lymph node status 
and avoid the significant morbidity associated with axillary clearance if the biopsied node is 
healthy [4]. The procedure involves removal of only the first lymph node on the lymphatic 
pathways draining a tumor. Even though sentinel node biopsy is less invasive than axillary 
clearance, lymphedema still occurs in up to 7% of patients [5]. Furthermore, only 42% of 
sentinel nodes contain metastases [6], indicating that uninvolved 'healthy' lymph nodes are 
excised in a significant proportion of cases. 
Alternative optical assessment techniques have been investigated with the goal of reducing 
the number of excised nodes. These techniques include fluorescence molecular imaging [7], 
elastic scattering spectroscopy [8,9] and optical coherence tomography (OCT) [10–13]. In 
previous studies, metastatic deposits in lymph nodes imaged with OCT were observed as 
regions of higher scattering relative to surrounding normal tissue, confirmed by comparison to 
histological sections [10,11]. In another study, metastatic lymph nodes were identified based 
on the loss of definition of the capsule/lymphoid junction when imaged with OCT through the 
capsule [12]. Such cancer detection with OCT is qualitative, as it is based on contrast that, for 
the same nominal tissue structure, can vary due to imaging artifacts and system variations. As 
a result, OCT images may not be comparable between different systems or different scanning 
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OCT. 
Quantitative measurement of optical properties based on analysis of OCT image data is a 
potential means of providing such repeatable contrast. Optical properties describe light 
propagation in tissue and have been measured assuming several models of OCT signal 
formation [14–16]. Optical properties such as the attenuation coefficient and backscattering 
coefficient have been extracted for healthy and diseased tissues of the cervix [17], arterial 
segments [18], human skin [19] and other tissues [14,20–22]. Earlier work has reported 
parametric OCT imaging of lymph nodes based on the relative optical attenuation coefficient 
extracted from OCT A-scans [23]. This work showed  a qualitative improvement in the 
differentiation of diffuse cancer and residual normal cortical tissue; however, absolute 
attenuation coefficients were not obtained and this work did not provide a characterization of 
healthy lymphoid tissues. 
In this paper, we take the next step in establishing the optical properties corresponding to 
lymph node pathology. We present a methodology to evaluate the absolute attenuation 
coefficients in excised human axillary lymph nodes. We extract local attenuation coefficients 
from 3D-OCT volumes and use these to generate quantitative parametric OCT images. We 
report ranges of attenuation coefficients of selected tissue regions and present parametric 
maps of tissue type based on these ranges. We verify the resulting mapping through 
correlation with histology and demonstrate that quantitative parametric OCT images provide 
improved differentiation of tissue type compared to standard OCT backscatter images alone. 
2. OCT signal model 
In the single-scattering model of light propagation in tissue, light contributing to the OCT 
signal is assumed to have experienced only a single back-scattering event. This model has 
been extensively applied for measuring optical attenuation of tissues ex vivo [18,24–27] and in 
vivo [28–30]. A model accounting for multiple scattering was also developed for highly turbid 
samples [31]. We employ the single-scattering model due to its simplicity and robustness in 
describing the OCT signal at low optical depths. Briefly, the returning power fraction, or 
reflectance  R(z), of light detected from a homogeneous tissue is determined from the 
exponential decay of irradiance versus depth z, in accordance with the Beer-Lambert law, 
 
2 () .
tz Rz e
µ ρ
− =    (1) 
The attenuation coefficient µt (mm
−1) describes this decay and is a result of scattering and 
absorption. The contribution of tissue absorption is very low at the near infrared wavelengths 
used in OCT and can be considered negligible in comparison to scattering [32]. The factor of 
2 in the exponent accounts for the double pass that singly back-scattered light makes through 
the tissue and ρ is the local reflectance given by the initial value of the reflectance,  ( 0) Rz= . 
The square of the detected OCT photocurrent 
2() iz , is a linear function of the reflectance 
R(z), and is modulated by system factors such as the numerical aperture of the optics and the 
OCT depth scan response. The OCT signal can be modeled as 
 
2() ()()() , i z FzSzRz ∝    (2) 
where F(z) represents the modulation due to the confocal aperture of the OCT system, and 
S(z) represents the modulation due to the OCT depth scan response. F(z) depends on the 
focusing and collection optics and has previously been termed a beam-divergence function 
[14], a confocal function [29], or an axial point spread function [33]. S(z) arises from coupling 
loss due to scanning the reference arm in time-domain OCT or from sensitivity drop-off in 
spectral-domain OCT. To correct for these modulations for our time-domain OCT system, we 
measured the signal from a homogeneous diffuse scattering phantom with known reference 
optical properties,  to µ  and  o ρ  (where the subscript o denotes a property of the phantom). 
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homogeneous phantom 
2() o iz , then 
 
2() ()() () , oo i z FzSzR z ∝    (3) 
with 
 
2 () .
toz
oo Rz e
µ ρ
− =    (4) 
Dividing the OCT signal acquired from a tissue by that from the homogeneous phantom, 
the tissue attenuation referenced to that of the phantom can be obtained: 
 
( ) ( )
2
2
2
(,,)
.
(,,)
t to z s
o o
i xyz
e
i xyz
µµ ρ
ρ
−− 
∝ 

   (5) 
To determine the theoretical values of  to µ  for the phantom, we used Mie theory to calculate 
the scattering coefficient  so µ  and anisotropy  o g , and relate these to the total attenuation [16] 
  ( ), to so o Ga g µµ =    (6) 
where  G  is a factor accounting for the extra path length of light rays travelling obliquely 
towards the focus (approximately one for the low numerical aperture used in OCT). The 
function a(g) gives a fraction between zero and one that diminishes the attenuation by taking 
into account forward scattered photons that, by nature of their forward trajectory, do not 
contribute to signal loss with depth. The function for  () ag was determined using Monte Carlo 
modeling and is given by [16] 
 
0.6651 (1 )
0.1555 () 1 .
g
ag e
−−
= −    (7) 
The correction phantoms for this study are described in Section 3.3 below. Lymph node 
tissue was assumed to consist of homogeneous regions of single tissue types sufficiently large 
to employ Eq. (5)  and extract µt  from the measured signal decay in each region. By 
subsequent careful assessment of tissue regions, the attenuation coefficient ranges for 
different lymphoid tissue types were determined. 
3. Materials and methods 
3.1 Optical coherence tomography imaging 
The OCT system used for generating three-dimensional data for imaging and attenuation 
measurement has been previously described [34]. The custom-built time-domain OCT scanner 
has a source center wavelength of 1320 nm and a 3-dB bandwidth of 154 nm (DenseLight 
Semiconductors, Singapore). The sample arm consists of an objective lens with a measured 
numerical aperture of 0.07, and a transverse scanning assembly with a scanning range (x-y) of 
3.5 × 6 mm. The measured lateral resolution of this assembly, given by the 1/e
2  beam 
diameter at the beam waist is ~11 µm in air. The measured axial resolution, given by the full 
width at half maximum of the axial point spread function is ~8 µm in air. Axial scanning was 
performed using a frequency-domain optical delay line in the reference arm that gave an axial 
scan range of 2.2 mm in air and an axial scan rate of 500Hz. The acquisition time for a full 
3D-OCT image was 30 minutes. The sampling density for these studies was 2.1 µm per pixel 
in the axial direction, and 3.4 and 5.9 µm per pixel in the x  and  y  lateral directions, 
respectively. The interference signal was detected using dual-balanced photodetectors, and the 
measured photocurrent converted to a voltage signal. The voltage signal was processed in 
hardware by band-pass filtering for noise reduction and signal smoothing, and logarithmic 
demodulation for envelope detection. The signal was acquired for processing after analog-to-
digital conversion with a detection sensitivity of −104 dB. 
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perpendicular to the imaging beam. A layer of phosphate-buffered saline (PBS) (n = 1.32) was 
employed between the glass window and lymph node samples, which improved refractive 
index matching and reduced the intensity of the specular reflection. Lymph node samples 
were imaged either through the capsule or from an exposed cut surface of the node. The focal 
plane of the imaging beam was set 500 μm (in air) beyond the window/tissue interface. Using 
geometrical optics to determine the change in refraction at the glass/tissue interface, the focal 
point changed to a depth of approximately 700 μm in tissue assuming a bulk group refractive 
index ntissue ~1.4. 
3.2 Sample preparation and histopathology 
Four axillary lymph nodes were obtained from breast cancer patients at Sir Charles Gairdner 
Hospital, Western Australia (SCGH). One was from a sentinel node biopsy, two were from 
axillary clearances from patients with early breast cancer, and the fourth was from an axillary 
clearance in a patient with advanced breast cancer who had received pre-operative adjuvant 
therapy. The protocol for this study was reviewed and approved by the SCGH Human 
Research Ethics Committee. Informed consent to use tissue was obtained from patients prior 
to surgery. After excision, lymph nodes were cut into 2mm-thick sections for assessment in 
accordance with standard procedure (PathWest Laboratory Medicine, Western Australia). A 
total of nine 2mm-thick samples were obtained and underwent OCT imaging within seven 
hours of excision. Samples were kept hydrated in PBS prior to imaging. 
Immediately following OCT imaging, samples were fixed in 4% w/v paraformaldehyde 
and prepared for histological processing. Fixed samples were paraffin embedded and a 5 μm 
thick  section  was  cut  at  approximately  200  μm  from  the  tissue  surface.  The  section  was 
stained with hematoxylin and eosin (H&E) for light microscopy analysis and digital image 
capture (Scanscope XT, Aperio Technologies  Inc., Vista, California) and subsequent co-
registration with OCT. 
An experienced pathologist identified morphologically distinct regions and tissue 
structures (referred to here as tissue types) from the digital H&E-stained histology images. 
Identification  of these tissue types facilitated comparison of the histology with the OCT 
images and the subsequently generated parametric attenuation images. The OCT data was 
displayed using in-house visualization software developed in C++, which allowed extraction 
of an arbitrary oblique imaging plane from the 3D-OCT data set. This technique, referred to as 
multiplanar reformatting in other medical imaging modalities, uses elementary linear algebra 
to generate the intersection of the 3D data volume with an arbitrary imaging plane. This 
allows visualization of imaging planes oriented at an angle to the en face directions to account 
for rotation of the histological specimens during fixation and processing. Histology and OCT 
images were manually co-registered by finding the optimal oblique plane in the 3D-OCT data 
set to visually match each histological section. Co-registered images were used to identify 
locations in the OCT volume at which to measure localized attenuation coefficients. 
3.3 Calibration and correction of A-scans 
Calibration 
Envelope detected OCT voltages were calibrated to corresponding values of reflectance at the 
sample using the known reflectance from a glass/air interface (4.05% reflectance at the 
imaging beam focus). The imaging beam was attenuated using  neutral density filters to 
generate a range of lower reflectance values and corresponding voltages, extending over the 
dynamic range of the system. Curve fitting of sample reflectance to log-demodulated OCT 
voltage was used to generate an empirical calibration curve with which to calibrate A-scans. 
Correction 
Uniform diffuse-scattering phantoms were imaged to measure and correct for the confocal and 
OCT depth scan response modulations in calibrated sample A-scans. The correction phantoms 
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Polysciences, Inc., USA) diluted in distilled water. Their optical properties were calculated 
using Mie theory with nwater = 1.322 and npolystyrene = 1.574 at 1320 nm [35]. The correction 
phantoms  were imaged immediately prior to lymph node imaging. OCT images of a 
representative  correction  phantom  (mean  microsphere  diameter  =  0.457  μm,  standard 
deviation = 0.011, concentration = 0.236% solids w/v) are presented in Fig. 1 and highlight 
the confocal and scanning modulations over the two orthogonal planes of imaging. From Mie 
theory and Eq. (6), with G = 1 and  ( ) 0.98 o ag = , we calculated 0.69 to µ =  mm
−1 for this 
phantom. 
Correction profiles were generated by averaging 77 A-scans at every lateral (x,y) position 
of the calibrated phantom data set in order to reduce the contribution of speckle noise to the 
correction (see Fig. 1(C)). The value of 77 was empirically chosen to be consistent with the 35 
× 35 μm (11 × 7 pixel) spatial averaging used to generate the final fitting profiles for tissue, as 
described in Section 3.4 below. These profiles were used to correct each lymph node data set 
as per Eq. (5) by dividing lymph node A-scans by the corresponding correction profile over 
depths at which the A-scan signal was above the noise floor. 
 
Fig. 1. OCT cross-sectional images of a representative microsphere correction phantom 
highlighting the confocal and scanning modulations over the (A) (y-z) range; and (B) (x-z) 
range. (C) Correction profile generated from the correction phantom 3D-OCT data set over the 
region indicted by the dotted lines in A and B. The back interface of the phantom is visible as 
the curved surface in the cross-sectional images and as a sharp peak of lower-intensity in the 
correction profile. 
3.4 Data analysis 
All data analysis was performed in MATLAB® 2009b (The Mathworks, Inc.) using Linux on 
a 16GB, Intel Quad Core i7, 2.80GHz machine. Custom algorithms were used to process, 
calibrate and correct 3D-OCT data sets and extract attenuation coefficients. Lymph node A-
scans were calibrated before being corrected with appropriate correction profiles to obtain 
final sample reflectance profiles. Prior to extraction of the attenuation coefficient, speckle 
noise was reduced by averaging reflectance profiles over a moving window 35 μm wide in 
both x and y directions (11 × 7 pixels, respectively). 
Attenuation coefficients were extracted using linear least-squares regression to fit the log 
of the averaged reflectance profiles. Fitting was performed over an axial range of 200 μm. 
Measurements were made at selected points by centering this range at the desired x, y, z 
location. The z-axis was scaled to correct for the difference between optical and physical path 
length in tissue, assuming a bulk group refractive index, ntissue = 1.4. Therefore, measured 
attenuation coefficients correspond to physical depth. The location of the window/tissue 
interface was set to z = 0 and en face parametric images were generated at selected depths z, 
by plotting the measured attenuation coefficients for each (x,y) location in the en face plane. A 
single parametric image required approximately 20 minutes to be generated on the machine 
described. Note that the algorithm implementation was not optimized for speed, but does lend 
itself to significant parallelization in future implementations. Parametric volumes were also 
generated by automating this process for several depths up to a maximum depth given by 
3 tz µ ≤  (~250 μm) in order to restrict fitting to regions where single scattering dominates. 
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values to the corresponding histology. 
Two homogeneous microsphere tissue phantoms were imaged to investigate the goodness-
of-fit of the least-squares regression. Linear least-squares regression for both phantoms gave 
median R
2 values of 0.7. Therefore, fits with R
2 < 0.70 were rejected for parametric images. A 
more stringent requirement of R
2 > 0.98 was used for recording attenuation coefficient ranges 
with improved accuracy, as these values were used to color map subsequent data. 
4. Results 
4.1 Attenuation coefficients of lymphoid tissue 
The attenuation coefficients were measured from selected locations within each of the nine 
lymph node sections imaged. A representative result from a healthy lymph node is presented 
in Fig. 2. Tissue regions of interest, identified from the corresponding H&E-stained histology 
in Fig. 2(A) are medulla, paracortex, fibrous capsule and adipose. The medulla is 
characterized by medullary sinuses (MS) traversed by light-pink staining fine reticular fibers 
and large pale-staining histiocytes. The sinuses are interspersed between cords of small, 
round, dark-purple staining lymphocytes. Lymphocytes also make up the surrounding 
paracortex (P), which also contains small blood venules and larger cells within a fibrous 
stroma. The thin, pink-staining fibrous capsule (FC) encases the lymph node and is composed  
 
Fig. 2. Measured attenuation coefficients for a section of healthy lymph node. (A) Co-
registered H&E-stained histology identifying tissue regions: MS, medullary sinuses (thick 
white arrow); P, paracortex (white double-headed arrow); FC, fibrous capsule (white 
arrowhead); and AT, adipose tissue (black arrow). (B) En face (x-y) OCT image at a depth of 
240 μm from the window/tissue interface. Colored boxes at this depth indicate regions over 
which attenuation coefficients were measured. (C) Parametric image of measured attenuation 
coefficients (mm
−1) with a custom color map. Points with R
2 < 0.7 for the fit are excluded and 
are shown in white. (D) An example of the correction profile (red) used to generate a corrected 
reflectance profile (black) from its raw A-scan (grey). The dashed region of the correction 
profile is not used in the correction as the reflectance profile is below the noise floor for this 
region. Resulting averaged reflectance profiles at the centre of the colored boxes given in A 
and B and their linear fittings with R
2 > 0.98 are shown in: (E) paracortex (dark blue); (F) 
medullary sinuses (light blue); and (G) fibrous capsule (red). Signal peaks at z = 0 are due to 
specular reflection from the window/tissue interface. Scale bars = 1 mm. 
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surround the node. 
In Fig. 2(B), two adjacent OCT images are superimposed. The OCT images show the 
perinodal adipose tissue is hyposcattering with a characteristic honeycomb appearance (light 
gray). Highly scattering curved regions at the periphery of the node are fibrous stroma of the 
capsule (dark gray). The lymphoid tissue exhibits medium scattering (gray) and is uniform in 
appearance. Features of interest within the lymphoid tissue, identified in the corresponding 
histology, are not obvious in the OCT image. There is evidence of external connective tissue 
in the perinodal adipose tissue, observable as linear reticulations of high scattering. 
Mean attenuation coefficients, averaged within 30  μm
2  areas, were recorded for the 
selected regions of each tissue type that are indicated by the colored boxes in the co-registered 
histology and OCT images in Figs. 2(A) and (B), respectively. The histology section was 
determined to be approximately 240 μm beyond the tissue surface based on the depth of the 
corresponding  en face  OCT image. Examples of the averaged reflectance profiles, and 
resulting attenuation coefficient measurements, for the three lymphoid tissue regions 
described are presented in Figs. 2(e)-(g). The specular reflection from the glass window/tissue 
interface corresponds to z = 0. There is a slight gap between the glass window and the surface 
of the tissue that is occupied by PBS, which was used to reduce the refractive index mismatch 
as the light beam entered the tissue and to keep the tissue hydrated. For a region of paracortex 
(dark blue box and Fig. 2(e)) the attenuation coefficient was measured to have a mean of 11.3 
mm
−1 and standard deviation of ±0.2 mm
−1 over the indicated area; for a medullary sinus 
(light blue box and Fig. 2(f))  t µ  = 8.7 ± 0.4 mm
−1; and for a region of fibrous capsule (red 
box and Fig. 2(g))  t µ  = 14.8 ± 0.5 mm
−1. 
Attenuation coefficients were measured for each tissue type at three representative sample 
locations as identified in corresponding histology. Sample locations were chosen from all nine 
sections imaged in this study. However, not all sections  contained each tissue type. The 
minimum and maximum attenuation coefficients obtained for each tissue type are presented in 
Fig. 3. Based on these ranges, thresholding was performed to generate a custom color map for 
segmenting tissue type and the resulting en face parametric image of attenuation is shown in 
Fig. 2(C). We observe segmented areas of medium attenuation (dark blue) in the outer area 
and a mixed low to medium attenuation (light blue) in the center upper area. This reflects the 
variation from paracortex to medulla seen in the histology. High attenuation (red), around 
sections of the node periphery, is attributed to the fibrous capsule. The outer region of 
perinodal adipose tissue has highly variable attenuation resulting from high standard errors of  
 
Fig. 3. Attenuation coefficient ranges for normal and reactive tissue regions in excised human 
axillary lymph nodes. 
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2 < 0.7, so this region appears mostly 
white in the parametric images. 
4.2 Parametric imaging of lymph nodes 
Figures 4 and 5 present the results of parametric imaging demonstrating enhanced contrast of 
tissue types, as compared to en face OCT imaging. Figure 4 shows a lymph node with a 
prominent cortex and a fatty hilum. Of note in the histology image in Fig. 4(A) are mono-
cellular regions of densely packed lymphocytes at the outermost region and a small central 
region of the node. These regions were identified as primary inactive cortical follicles (PF). 
The histology also shows  clusters of unstained circular adipocytes (A) and gaps of 
lymphovascular spaces (LVS) cut in cross section and distinguishable from adipocytes by a 
thin wall of dense fibrous stroma. A thin fibrous capsule (FC) also lines the periphery of the 
node. A lighter-staining mottled region of paracortex (P) is evident as well as some medullary 
sinuses (MS) in the central region of the node. These regions are highlighted in the zoomed 
lower panels in Fig. 4. Several small vessels (V) can also be seen cut longitudinally in the 
paracortex in the magnified image. 
The corresponding OCT image in Fig. 4(B) depicts scattering lymphoid tissue surrounded 
by hyposcattering adipose tissue with a diffuse border. High scattering is seen in some regions 
corresponding to the fibrous capsule, but artifacts caused by adipose tissue in superficial 
layers confound the border of adipose and lymphoid tissue. Artifacts (AF) account for much 
of the variation observed in the OCT image: high-signal (black) streaking from adipocytes can 
be seen in the upper left and center of the image, and artifacts due to shadowing from 
superficial vessels are evident in the paracortex. Within the node, some adipocytes and 
lymphovascular spaces are evident as white gaps corresponding with histology. Variable 
scattering within the node may be attributable to distinct tissue types, but the highlighted 
regions (boxes) do not show sufficient contrast to be distinguishable. Figure 4(C) presents a  
 
Fig. 4. Healthy lymph node with prominent cortex and fatty hilum. (A) Co-registered H&E-
stained histology identifying tissue regions and features of interest: PF, primary inactive 
cortical follicles (thin white arrow); P, paracortex (white double-headed arrow); MS, medullary 
sinuses (thick white arrow); AT, adipose tissue (thin black arrow); FC, fibrous capsule (white 
arrowhead); A, adipocytes (black arrowhead); LVS, lymphovascular spaces (thick black 
arrow); V, vessels (black asterisk). (B) En face (x-y) OCT image at a depth of 240 μm from the 
window/tissue interface. Superficial adipocytes cause AF, artifact (white asterisk) in the OCT 
image. (C) Gray-scale parametric image of measured attenuation coefficients (mm
−1). (D) 
Parametric image presented with a custom color map. Lower panels 2.5 × magnified regions 
represented by white dashed boxes in the corresponding upper panels. Colored boxes indicate 
regions of distinct tissue type over which attenuation coefficients were measured: primary 
inactive cortical follicles (green); paracortex (dark blue); medullary sinus (light blue); fibrous 
capsule (red). Scale bars = 1 mm. 
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Compared with the OCT image (Fig. 4(B)), the parametric image displays greater contrast 
between the tissue regions of interest and improved identification of features such as vessels, 
adipocytes and lymphovascular spaces that correspond well with histology (Fig. 4(A)). 
The vessel walls (V) are highly attenuating and are readily identified in the parametric 
images. Also of particular interest are regions of primary inactive cortical follicles, 
recognizable from their low attenuation (light gray) in the selected region (green box) with  t µ  
= 6.3 ± 0.5 mm
−1. The region of fibrous capsule (red box) has high attenuation (dark gray)  t µ  
= 14.4 ± 0.3 mm
−1. There is less contrast between the region of paracortex (dark blue box)  t µ  
= 10.6 ± 0.4 mm
−1 and medulla (light blue box)  t µ  = 8.9 ± 0.2 mm
−1. Based on the measured 
attenuation coefficients these tissues can be quantitatively differentiated and segmented as 
depicted in Fig. 4(D). The custom color map, which is the same as used for Fig. 2, enhances 
the contrast between the paracortex and medullary regions and aids their differentiation. 
Comparing the parametric image of this node to that of the previous node in Fig. 2, we see 
that the classification of tissue type is consistent. 
Figure 5  presents results from a lymph node that is reactive in response to adjuvant 
therapy for pre-operative tumor treatment. The histology image in Fig. 5(A) shows a localized 
region of necrotic tissue (N) with dystrophic calcifications (C), highlighted by the beige and 
yellow boxes respectively. The necrotic tissue is interpreted to be treated tumor cells and has a 
uniform, pink-staining, fragmented appearance. The core of the necrotic area contains dark-
purple staining foci of calcifications. There is a loss of normal tissue architecture in response  
 
Fig. 5. Reactive lymph node with an area of necrotic tissue containing dystrophic calcifications 
and a loss of normal tissue architecture. (A) Co-registered H&E-stained histology identifying 
tissue regions of interest: N, necrotic tissue (thick black arrow), C, calcifications (black 
arrowhead), TFC, thickened fibrous capsule (white arrowhead); AT, adipose tissue (thin black 
arrow), P, paracortex (white double-headed arrow), MS, medullary sinuses (thick white arrow). 
(B) En face (x-y) OCT image at a depth of 240 μm from the window/tissue interface. (C) Gray-
scale parametric image of measured attenuation coefficients (mm
−1). Sharp tissue interfaces 
particularly at the capsule cause AF, artifacts (white asterisk) in the attenuation measurement. 
(D) Parametric image of attenuation coefficients presented with a custom color map. Lower 
panels 2 × magnified regions represented by white dashed boxes in the corresponding upper 
panels and colored boxes indicate regions of distinct tissue type over which attenuation 
coefficients were measured: necrotic tissue (beige); foci of dystrophic calcification (yellow); 
thickened fibrous capsule (blue); medullary sinus (light blue); paracortex (dark blue). Scale 
bars = 1mm. 
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capsule (TFC) and a medulla with constricted sinuses (MS) making it difficult to distinguish. 
The OCT image in Fig. 5(B) exhibits imaging artifacts caused by streaking of superficial 
adipocytes that make it difficult to delineate the capsule. There is high scattering in the 
external adipose tissue, which is in agreement with the presence of connective tissue in the 
corresponding areas in the histology. The necrotic tissue is not well distinguished due to these 
artifacts and it is unclear if it is part of the lymphoid region or part of the external connective 
tissue. 
The grayscale parametric image in Fig. 5(C)  clearly depicts the necrotic region and 
calcifications by the high contrast in their attenuation coefficients. A region of necrotic tissue 
(orange box) has high attenuation (dark gray)  t µ   = 13.4 ± 0.4 mm
−1  and a focus of 
calcification (yellow box) has very high attenuation (black)  t µ  = 16.0 ± 0.4 mm
−1. Thus, 
distinction of the necrotic tissue is possible using parametric imaging. Unique identification 
may be compromised when compared to areas of the capsule showing similar attenuation, 
such as the upper border. However, this region also exhibits artifacts that are not present in the 
necrotic tissue, observable as outliers of hyper-attenuation displayed as black in the color-
mapped parametric image in Fig. 5(D). Such outliers are due to the sharp interface from one 
tissue type to another, especially the interface to the thin fibrous stroma of the capsule, where 
the fitting range is larger than the distance over which the tissue extends. Improvement of the 
method is needed to increase the specificity for differentiating necrotic and capsular tissue. 
The parametric image in Fig. 5(D) presents the thickened reactive fibrous capsule (blue) 
with lower attenuation,  t µ  = 11.8 ± 0.2 mm
−1, than normal anatomical capsule (red). It is 
present around the left and lower periphery of the node, while areas of intact normal capsule 
remain at the upper and right borders of the node, in agreement with histology. The paracortex 
(dark blue) has similar attenuation to the thickened capsule with  t µ  = 10.4 ± 0.4 mm
−1, which 
is consistent with a greater population of lymphocytes and less collagen in these areas. The 
fibrous border around the necrotic tissue exhibits attenuation overlapping both paracortical 
and medullary ranges (light blue to dark blue). It is evidently a different tissue type though not 
uniquely distinguished by its attenuation. Finally, we observe low attenuation in the center-
most region, which is consistent with medulla  t µ  = 8.3 ± 0.2 mm
−1, although there is very low 
attenuation in the center of the medulla that suggests a separate composition. There may be 
two reasons for this: firstly, the section was cut at an angle to the en face OCT image plane so 
that the variation may not match to the plane of histology shown; secondly, the tissue in this 
region may be subtly different in its architecture and morphology than either paracortical or 
medullary tissue, but not so well defined in the histology that it can be classified. Improved 
correlation to histology is needed in this case to determine the tissue type and how it differs in 
morphology from other regions. The current study concentrates on establishing the basic 
feasibility of the method but a more extensive study will be required to resolve such 
ambiguities. 
5. Discussion 
5.1 Attenuation coefficients and parametric imaging 
We have used OCT to measure absolute, localized attenuation coefficients of healthy inactive 
and reactive human axillary lymph nodes. Based on these measurements, we have generated 
parametric images of the attenuation coefficient and correlated these with histology to identify 
the characteristic attenuation coefficients for selected tissue types. Attenuation coefficients 
within normal lymph nodes ranged from 4.5 to 15.3 mm
−1. The lowest measured attenuation 
coefficient was  t µ  = 4.5 mm
−1 for regions of primary inactive cortical follicles. Regions of 
paracortex and medullary sinuses had intermediate attenuation coefficients ranging from 8.1 
to 11.5 mm
−1. High attenuation  t µ  > 14 mm
−1 was measured for the fibrous capsule in all of 
the samples. In comparison, reactive thickened fibrous capsule in a node containing an area of 
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−1. Importantly, these 
measured attenuation coefficients are system-independent and absolute since, having 
accounted for the system confocal and OCT depth scan responses, the signal decay is a direct 
measure of tissue attenuation. 
In the node containing necrotic tissue, which was interpreted to represent a reaction to pre-
operative therapy, high attenuation was measured for the necrotic region  t µ  ≈13 mm
−1 and 
very high attenuation was measured for foci of dystrophic calcifications  t µ  > 16 mm
−1. The 
necrotic tissue in this case was the result of adjuvant therapy, but regions of necrotic tissue are 
also observed in metastatic deposits of untreated breast cancer. We expect the attenuation 
characteristics for malignant metastatic deposits to be higher than normal lymphoid tissue, as 
indicated in the results from this study and from the results in [23]. This is expected since 
metastatic deposits have enlarged cells with increased organelle and cell density, contributing 
to increased scattering. 
Our results show good agreement with previously reported measurements of attenuation 
coefficients in soft tissues: human arteries with atherosclerotic plaques, measured with OCT at 
800 nm, gave  t µ  = 3.2 to 9.5 mm
−1 for normal arterial tissue;  t µ  = 11.1 mm
−1 for calcified 
plaques [18]; and at 1310 nm  t µ  >10 mm
−1  for necrotic core [30]. Similarly for normal 
porcine arterial tissue at 1320nm,  t µ  ranged from 1.19 to 15.88 mm
−1 [36]. Measurements of 
light transmission in breast tissue gave an attenuation coefficient of  t µ  = 8.3 ± 2.0 mm
−1 at 
830 nm [37]. Also the median attenuation coefficient measured using OCT at 1300 nm for 
normal renal tissue was  t µ  = 4.95 mm
−1 and for renal cell carcinoma was  t µ  = 8.86 mm
−1 
[22]. While necrotic tissue was found to have high optical attenuation, it was observed to be 
lower than healthy fibrous tissue (i.e. fibrous capsule, Fig. 3). This is in agreement with earlier 
work which induced necrosis in human fibroblasts, and found necrotic cells exhibited a 
corresponding decrease in attenuation [38]. 
The attenuation coefficient of the tissue types presented here aids differentiation, however, 
it is not always a unique identifier. We also take into account the locations and geometries in 
correctly identifying tissue types. The fibrous capsule, for example, is distinguishable from 
necrotic tissue by its thin curved appearance, and follicular tissue, which lies in the cortical 
area, is distinct from medullary sinuses, which lie away from the periphery. More accurate 
differentiation of tissue types is possible by interpreting localized attenuation coefficients in 
combination with morphological appearance in the parametric images. The color mapping of 
parametric images, as presented here, enhances contrast and improves the ability to visually 
identify tissue type. Similar conclusions have been drawn in parametric imaging of 
atherosclerotic plaques [18,25,30]. In comparison, methods based on point-by-point optical 
parameter measurement must rely on obvious differences in optical properties, such as 
between adipose and fibrous tissue [39,40], or else use computational analysis to efficiently 
assess many parameters simultaneously [17,41,42]. We note that an extension to two-
parameter imaging was recently demonstrated in atherosclerotic plaques and in tissues of the 
anterior eye [26] and showed further improvement in tissue contrast and characterization 
beyond that achieved with one-parameter mapping. 
5.2 Methods, study limitations and future work 
The single scattering model, modulated for confocal and scanning corrections, proved robust 
and adequate for measuring and differentiating the attenuation coefficients of human lymph 
node tissues at low optical depth. The analysis and parametric imaging algorithms may be 
improved by further optimization, such as increasing the number of averaged A-scans for 
greater speckle reduction, or altering the fitting range based on the expected homogeneity of 
selected regions. Though our fitting range was kept constant at 200 μm, we moved this range 
over all locations, finding the maximum number of homogeneous regions for which it was 
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2 < 0.7 in images, 
R
2 < 0.98 in tabulated values). 
A limitation of the method reported here was the speed of acquisition and processing. The 
presented images were obtained from ex vivo samples using a TD-OCT system with high 
image quality, but slow acquisition speed. The method is readily transferable to higher scan 
speed spectral-domain OCT systems to address this issue. Processing of large 3D data sets 
(3.5 × 6 × 2 mm) is also computationally intensive but lends itself to optimization through 
highly parallel algorithm implementation. The issue of in vivo imaging has been addressed 
separately [43] by using miniature probes incorporated into needles to increase penetration 
depth, implemented using a portable spectral-domain OCT system. 
Co-registration of the histology was made difficult in some cases because of tissue 
deformation and shrinkage caused by the fixation, processing and mounting procedures [44] 
[45]. We sampled the histology sections at a depth of approximately 200 μm, but distortion 
during histological processing meant that the histology section did not necessarily correspond 
to a flat plane in the OCT scan of the  fresh tissue. Co-registration with histology was 
generally easier with the parametric images than with OCT, since the contrast between tissues 
was improved. Artifacts in the parametric images were still present but were less disruptive 
than those affecting OCT because of the improved contrast between different tissue types. 
Artifacts were observed when the computed parameters corresponded to heterogeneous 
regions of tissue. This also occurred where tissue structures were very thin, such as the lymph 
node capsule. We attempted to exclude regions of inhomogeneity from the images by 
rejecting fits with high standard errors of the regression. An alternative technique has also 
been proposed in which fitting was performed over a variable range until a decrease in fit 
quality was observed [30]. 
The results presented here represent a baseline in the use of this technique and are a first 
step towards establishing its use in a clinical setting. The promise of the results suggests that a 
larger study with more patients and more sampling regions is warranted. Such an expanded 
study would help to establish statistical accuracy as well as improve the accuracy and 
reliability of the thresholding map. 
6. Conclusions 
In this paper, we have reported a method to characterize and improve differentiation of 
healthy and reactive tissue types in human axillary lymph nodes using parametric imaging. 
The method uses a single-scattering model of OCT to measure attenuation coefficients at low 
depths. We applied this model to ex vivo lymph node sections to measure the attenuation 
coefficients of medullary sinuses, paracortex, primary inactive cortical follicles, fibrous 
capsule, necrotic tissue and dystrophic calcifications. We showed that parametric imaging of 
the attenuation coefficient enables enhanced differentiation of these tissue types compared to 
standard OCT. Based on previous OCT imaging of lymph nodes, we expect that cancer 
metastasis will be detectable based on high attenuation and we have measured attenuation in 
healthy and reactive nodes as a first step towards this. Since the presented analysis is based on 
quantification of intrinsic tissue attenuation, contrast is transferable between samples and 
between scans with minimal effect from system variations. We believe this methodology 
provides an important improvement to OCT imaging of lymph node morphology and is a step 
towards in situ assessment of lymph nodes using OCT. 
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